EGF and non-small cell lung carcinoma: Growth rates decreased in A549 cells beginning 48 h after EGF treatment compared to control cells (at 48 h, 74 ± 6% vs. 198 ± 7%; at 72 h, 58 ± 28% vs. 322 ± 24%; and at 96 h, 196 ± 23% vs. 499 ± 20% in EGF-treated vs. control cells, respectively; Figure 1A Results obtained using other NSCLC cell lines (EKVX, H23, H322M, and H226 cells; Supplementary Table S1) were similar to those observed in A549 cells (Figure 1A).